Braskem(BAK)
Search documents
Braskem(BAK) - 2023 Q2 - Earnings Call Presentation
2023-11-06 19:44
EARNINGS CONFERENCE CALL 2Q23 AUGUST 9 , 2 0 2 3 ...
Braskem(BAK) - 2023 Q2 - Earnings Call Transcript
2023-08-16 22:00
Braskem S.A. (NYSE:BAK) Q2 2023 Earnings Conference Call August 16, 2023 11:00 AM ET Company Participants Rosana Avolio - Investor Relations Pedro Freitas - Chief Financial Officer Roberto Bischoff - Chief Executive Officer Conference Call Participants Gabriel Barra - Citibank Pedro Soares - BTG Pactual Rodrigo Almeida - Santander Luiz Carvalho - UBS Anne Milne - Bank of America Operator Good morning and thank you for waiting. Welcome to this conference call to discuss Braskem’s Second Quarter of 2023 Resul ...
Braskem(BAK) - 2023 Q1 - Earnings Call Transcript
2023-05-09 19:46
Financial Data and Key Metrics Changes - In Q1 2023, Braskem reported recurring EBITDA of $205 million and net profit of $184 million, with cash consumption of $261 million [4][5] - The company maintained solid credit metrics with a long debt profile and strong liquidity, covering debt maturities for the next six years [4][13] - Corporate leverage was reported at 3.86 times, reflecting lower EBITDA compared to the same quarter of the previous year [13] Business Line Data and Key Metrics Changes - In Brazil, the petrochemical crackers operated at an average utilization rate of 77%, a 5 percentage point increase from the previous quarter, with a 3% increase in domestic sales volume and a 10% increase in exports [7] - The United States and Europe segment had a capacity utilization rate of 81%, a 6 percentage point increase, with a sales volume of 518 tons [10][11] - In Mexico, the utilization rate was 72%, a 3 percentage point increase, with an 11% increase in sales volume [12] Market Data and Key Metrics Changes - The global accident frequency rate decreased by 8% compared to the same period in 2022, indicating improved safety performance [5] - The company experienced better performance in global industrial activity, leading to increased sales volume across all segments [6] Company Strategy and Development Direction - Braskem is focusing on expanding its green ethylene capacity by 30% and has made progress in the construction of an ethane terminal in Mexico [5] - The company is committed to maximizing cash generation and optimizing asset operations while pursuing initiatives related to sustainability and innovation [14][16][21] - The strategic focus includes investments to combat climate change and eliminate plastic waste, alongside enhancing innovation and digital transformation [21] Management's Comments on Operating Environment and Future Outlook - Management noted that the pace of international demand growth is uncertain, but they will continue to seek strategies to maximize synergies across regions [72] - The company expects stable production levels in Brazil and increased sales volume in the U.S. and Mexico for Q2 2023 [20] Other Important Information - Braskem has made significant provisions related to the geological event in Alagoas, totaling BRL 13.2 billion, with BRL 7.5 billion already disbursed [8] - The company has invested in expanding its technology and innovation centers, with a focus on sustainable development [16][17] Q&A Session Summary Question: Potential sale of Braskem and minority shareholder rights - Management confirmed that in the event of a sale, minority shareholders would have tag-along rights for 100% of shares [24][25][28] Question: Working capital dynamics and petrochemical prices - Management indicated that working capital utilization is expected to remain positive, with a focus on monitoring oil prices and product prices [29][30] Question: Conversations with rating agencies - Management emphasized the importance of maintaining close relationships with rating agencies and noted that leverage expectations align with agency requirements [34][35] Question: M&A risks and potential synergies with ADNOC - Management acknowledged potential synergies with ADNOC but emphasized the need for further analysis of any proposed transactions [38][39] Question: Changes in leadership and company strategy - Management reiterated that the company remains committed to its growth strategy, focusing on bio products and circular economy initiatives [44][45] Question: Impact of arbitration and covenant risks - Management stated that the arbitration process is confidential and confirmed that there are no covenants for corporate debts [48][49]
Braskem(BAK) - 2023 Q1 - Earnings Call Presentation
2023-05-09 17:05
EARNINGS CONFERENCE CALL 1Q23 M AY 9 , 2 0 2 3 PUBLIC FORWARD-LOOKING STATEMENTS This presentation includes forward-looking statements. These forward-looking statements represent not solely historical data, but also reflect the goals and expectations of Braskem's management. The terms "anticipate," "believe," "expect," "foresee," "intend," "plan," "estimate," "project," "aim" and similar terms are used to indicate forward-looking statements. Although we believe these forward-looking statements are based on ...
Braskem(BAK) - 2022 Q4 - Annual Report
2023-04-24 16:00
Financial Position - As of December 31, 2022, the company had currency options with an aggregate notional amount of US$2.1 billion (R$10.96 billion) in puts and US$1.4 billion (R$7.3 billion) in calls[1255]. - The company had R$8.3 billion (US$1.6 billion) in foreign currency-denominated cash and cash equivalents as of December 31, 2022[1257]. - U.S. dollar-denominated debt amounted to R$43.3 billion (US$8.3 billion) as of December 31, 2022, compared to R$47.8 billion (US$8.6 billion) in 2021[1264]. - The company had total loans and financings of R$47.96 billion (US$9.1 billion) as of December 31, 2022[1261]. Interest Rates - The short-term domestic CDI rate increased to 13.65% per annum as of December 31, 2022, up from 4.4% per annum in 2021[1258]. - The average interest rate for fixed-rate loans denominated in U.S. dollars was 6.1% for 2023 and 6.5% for 2024[1261]. - The average interest rate for variable-rate loans denominated in reais was 14.1% for 2023[1261]. Risk Management - The company maintains a conservative risk management policy to mitigate market risks, including foreign exchange and commodity risks[1256]. - The company does not hedge the exposure to the price of naphtha, its principal raw material, which could adversely affect financial results[1266]. - If the real depreciated by 10% against the U.S. dollar during 2022, financial expenses indexed to the dollar would have increased by R$4.3 billion[1265]. Internal Control - Management assessed the effectiveness of internal control over financial reporting as of December 31, 2022, concluding that effective controls were maintained[1275]. - There were no changes to internal control over financial reporting during the year ended December 31, 2022, that would materially affect the controls[1279]. - Remediation actions taken in 2022 addressed a material weakness reported as of December 31, 2021, and the company concluded that this weakness was remediated by December 31, 2022[1278]. - The company plans to improve hedge accounting control descriptions and provide training for personnel involved in transactional activities related to hedge accounting[1277]. Corporate Activities - The company received US$611.9 thousand from the depositary of its ADSs during the year ended December 31, 2022, for general corporate purposes[1270].
Braskem(BAK) - 2022 Q4 - Annual Report
2023-04-24 16:00
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of April, 2023 (Commission File No. 1-14862 ) BRASKEM S.A. (Exact Name as Specified in its Charter) N/A (Translation of registrant's name into English) Rua Eteno, 1561, Polo Petroquimico de Camacari Camacari, Bahia - CEP 42810-000 Brazil (Address of principal executive of ices) Indicate by check mark whether the registrant ...
Braskem(BAK) - 2022 Q3 - Earnings Call Transcript
2022-11-10 00:18
Braskem S.A. (NYSE:BAK) Q3 2022 Earnings Conference Call November 9, 2022 9:00 AM ET Company Participants Rosana Avolio - Director of Investor Relations, Strategic Planning and Market Intelligence Pedro Freitas - Chief Financial Officer Roberto Simões - Chief Executive Officer Conference Call Participants Pedro Soares - BTG Pactual Bruno Montanari - Morgan Stanley Leonardo Marcondes - Bank of America Merrill Lynch Vicente Falanga - Banco Bradesco BBI S.A. Luiz Carvalho - UBS Group AG Gabriel Barra - Citigro ...
Braskem(BAK) - 2022 Q2 - Earnings Call Transcript
2022-08-13 12:08
Braskem SA (NYSE:BAK) Q2 2022 Earnings Conference Call August 11, 2022 1:30 PM ET Company Participants Rosana Avolio - IR Manager Pedro Freitas - CFO Danilo Garcez - Mexico CFO Conference Call Participants Guilherme Levy - Morgan Stanley Luiz Carvalho - UBS Leonardo Marcondes - Bank of America Merrill Lynch Barbara Halberstadt - JPMorgan Chase & Co. Gabriel Barra - Citigroup Operator Good afternoon, and thank you for standing by. Welcome to conference call for Braskem's Third Quarter Earnings Results Call f ...
Braskem(BAK) - 2022 Q1 - Earnings Call Transcript
2022-05-12 18:38
Braskem SA (NYSE:BAK) Q1 2022 Earnings Conference Call May 12, 2022 10:00 AM ET Company Participants Rosana Avolio - IR Manager Pedro Freitas - CFO Roberto Simoes - CEO & Director Conference Call Participants Guilherme Levy - Morgan Stanley Pedro Soares - BTG Pactual Vicente Falanga - Bradesco BBI Luiz Carvalho - UBS Gabriel Barra - Citigroup Operator Good morning, and thank you for waiting. Welcome to Braskem's Q1 2022 Earnings Conference. With us today, we have Mr. Roberto Simoes, CEO; Pedro Freitas, CFO; ...